Chronic stable disease - drug therapy

COPD management involves treatment of chronic stable disease and of exacerbations.¹ Treatment of chronic stable COPD aims to prevent exacerbations and improve physical function through a combination of drug and non drug therapy options.

Table 1: Summary of the drug therapy options for COPD. ^1-10

References

1. Global Initiative for chronic obstructive lung disease: Global strategy for the diagnosis, management, and prevention of COPD. 2010. www.goldcopd.org  
2. Complete prescribing information for VENTOLIN^®. Available at http://us.gsk.com/products/assets/us_ventolin_hfa.pdf. Updated June 2009.
3. BRICANYL^® TURBUHALER^®. Information for the consumer. Available at http://www.astrazeneca.ca/documents/ProductPortfolio/BRICANYL_CIL_en.pdf. Updated December 2005.
4. SEREVENT^® Patient information leaflets. Available at http://public.gsk.co.uk/products/serevent. Updated May 2011.
5. FORADIL^® prescribing information. Available at http://www.spfiles.com/piforadil.pdf. Updated May 2011.
6. ATROVENT^® Patient information leaflet. Available at http://emc.medicines.org.uk/medicine/14341. Updated March 2011.
7. SPIRIVA^® Patient information leaflet. Available at http://emc.medicines.org.uk/document.aspx?documentId=16286. Updated February 2011.
8. Theophylline Drug information, FDA Official source. Available at http://www.drugs.com/cdi/theophylline.html. Updated October 2011.
9. SERETIDE^® Patient information leaflet. Available at http://emc.medicines.org.uk/medicine/3762. Updated September 2011.
10. SYMBICORT^® TURBUHALER^® Consumer information. Available at https://www.astrazeneca.ca/documents/ProductPortfolio/SYMBICORT_CIL_en.pdf. Updated May 2011.